Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients
- 2 July 2016
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 60 (1) , 91-93
Abstract
B cells are being recognized as one of the major players in the pathogenesis of multiple sclerosis (MS). The B cell activating factor (BAFF) system plays an essential role in B cell homeostasis and function in the periphery. Mycobacterium avium subspecies paratuberculosis (MAP) has been previously associated to MS in Sardinia. Antibodies against a MAP surface protein, MAP_2694, have been found significantly associated to MS patients, and this response was modified by interferon-β therapy. Increased BAFF levels following IFN-β therapy have been also described in MS patients. In this study, we evaluated whether soluble BAFF levels are comparable in men and women affected by MS and performed a correlation of the reported BAFF increase in MS patients under IFN-β therapy with changes of humoral response against MAP_2694. For these reasons, we investigated 44 MS patients before and after IFN-β therapy. A significant difference of BAFF levels was found between men and women with MS; moreover, we confirmed that IFN-β therapy strongly induces BAFF serum levels, but this was not related to the modification of immunological response against MAP_2694. In conclusion, our study highlights that IFN-β therapy induces the potent B cell survival factor BAFF without alterations of the humoral immune response against MAP.Keywords
Funding Information
- FISM
- Fondazione Banco di Saredgna
This publication has 9 references indexed in Scilit:
- Changes in Blood B Cell-Activating Factor (BAFF) Levels in Multiple Sclerosis: A Sign of Treatment OutcomePLOS ONE, 2015
- Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patientsJournal of the Neurological Sciences, 2015
- Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patientsMultiple Sclerosis Journal, 2014
- Epstein–Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patientsJournal of Neuroimmunology, 2014
- Metabolic Reprogramming Is Required for Antibody Production That Is Suppressed in Anergic but Exaggerated in Chronically BAFF-Exposed B CellsThe Journal of Immunology, 2014
- Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical featuresMultiple Sclerosis Journal, 2013
- Association of Mycobacterium avium subsp. paratuberculosis with Multiple Sclerosis in Sardinian PatientsPLOS ONE, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunityBrain, 2008